Theragen Etex is a leading pharmaceutical and biotechnology brand specializing in personalized genomics and precision medicine. With a strong focus on genomic sequencing and analysis technologies, Theragen Bio, a subsidiary of Theragen Etex, provides customized diagnostic solutions and next-generation sequencing services. They export their cutting-edge genome analysis technologies to over 40 countries, establishing themselves as leaders in the field of precision medicine.

Theragen Etex itself is dedicated to the production and supply of approximately 200 medicines. With a KGMP production facility and nine branches across the country, they efficiently manufacture and distribute a wide range of medicines, including incrementally modified drugs. Additionally, Theragen Etex Group is actively involved in genetic analysis services and the development of personalized new drugs.

Furthermore, through its subsidiaries, Theragen Etex is committed to the distribution of medical supplies, the development of novel anticancer drugs, and non-invasive prenatal diagnosis services. They strive to enhance market competitiveness by utilizing state-of-the-art technologies and collaborating with internal and external medical networks. Overall, Theragen Etex is at the forefront of the precision medicine industry, aiming to improve health outcomes through advanced genomics and pharmaceutical innovation